A certificate of analysis, or CoA, is the single most useful document you can ask for Ministry seeds when choosing medical cannabis. It is the lab report that tells you what is actually in a batch of medicine: how much active cannabinoid is present, which terpenes give it flavor and effect, whether pesticides or heavy metals are present, and whether the product meets basic safety standards. For patients and clinicians who rely on consistent symptom relief, learning to read a CoA converts guesswork into an evidence-informed choice.
Why it matters
For a patient, the difference between a labeled 20 percent THC product and the tested result can be the difference between relief and side effects. For a caregiver or clinician, misreading potency or mistaking THCA for active THC can lead to dosing errors. I have seen patients who switched products after checking a CoA and reduced their dose by half because the tested total THC was higher than expected. That change cut both anxiety and unwanted sedation. A CoA is not just bureaucratic paper; it affects safety, efficacy, and value.
The anatomy of a typical CoA
A CoA has several recurring sections. Labs vary in layout and vocabulary, but the same core information appears across reputable reports. Expect these elements and know where to look for them.
Header and sample metadata The top portion usually names the testing laboratory and includes accreditation information, often an ISO 17025 statement if the lab is accredited. There will be a unique report or certificate number, a batch or lot number that should match the product you hold, a sample description (flower, oil, edible), the client or producer name, and both the date sampled and the date tested. Chain of custody details hemp may appear. If the report lacks a clear sample identifier or dates, treat it with suspicion.
Cannabinoid profile and potency This is the most commonly read section. It lists individual cannabinoids such as THC (delta-9 tetrahydrocannabinol), THCA (tetrahydrocannabinolic acid), CBD (cannabidiol), CBDA, CBG, CBC, and sometimes trace cannabinoids. Look for units, typically percent by weight (% w/w) or milligrams per gram (mg/g). A common point of confusion is how labs report “total THC.” Because THCA decarboxylates into THC when heated, many labs provide total THC calculated as THC + (THCA × 0.877). The 0.877 factor converts the heavier acid molecule to the lighter neutral form after loss of CO2. If a label and the CoA disagree, check whether the label is quoting total THC or just THC. That distinction matters for dosing.
Terpene profile Terpenes drive aroma and can modestly influence effect. A CoA will often list major terpenes with concentration in percent or mg/g: myrcene, limonene, pinene, caryophyllene, linalool, and others. Terpene content in flower typically falls between about 0.5 and 3 percent total, but concentrates and extracts can show much higher totals. If the terpene totals are reported as unusually low for a cured flower, that can indicate poor handling or age.
Contaminants This section is about safety. Tests can include pesticides, residual solvents, heavy metals (lead, cadmium, arsenic, mercury), microbial contaminants (total yeast and mold counts, E. coli, Salmonella), and mycotoxins. For edibles and concentrates, residual solvents are important; look for methods such as GC-MS or headspace GC indicated on the report. Pesticide results are usually given in parts per million or parts per billion. If the CoA shows a detected pesticide, the report should list the compound, the measured concentration, and often the method detection limit (LOD) and limit of quantitation (LOQ).
Stability, impurities, and potency uncertainty Some reports include a stability or degradation note, especially for extracts or edibles. Others provide measurement uncertainty — a confidence interval around the quantitative results. A responsible lab will show LOQ and LOD values for each analyte and sometimes report values below quantitation as “< LOQ.” That distinction tells you whether the compound is truly absent or simply below the lab’s reporting capability.
Methods and accreditation Look for the testing method names and reference standards: HPLC for cannabinoids is standard, GC-MS for many terpenes and residual solvents, ICP-MS for metals. An ISO 17025 accreditation statement from an appropriate body, or an indication that the lab follows validated methods, increases confidence. If methods are absent or vaguely described, the report is less reliable.
A practical reading checklist
confirm batch or lot number, sample description, and dates match the product you have; 2. check the cannabinoid table for both THC and THCA and note whether the lab reports total THC using the 0.877 conversion; 3. note the units used for potency and contaminants and convert when necessary so you compare apples to apples; 4. review contaminant sections for any detected pesticides, heavy metals, or microbial failures; 5. verify lab accreditation and method names to assess reliability.How to interpret key numbers
Percent vs mg/g A common unit for flower potency is percent by weight. For example, 20 percent total THC equals 200 mg of THC per gram of flower. If a CoA reports 12 mg/g CBD, that is equivalent to 1.2 percent CBD. Concentrates often use mg/g because total percentages can exceed 100 when summing cannabinoids and terpenes due to reporting conventions; stick to the units provided.
Total THC calculation Remember the conversion factor: total THC = THC + (THCA × 0.877). For example, a sample with 0.5 percent THC and 18 percent THCA has total THC = 0.5 + (18 × 0.877) = approximately 16.3 percent. Labels that report “THC” without stating total or non-decarboxylated forms can be misleading for dosing.
Pesticides and parts per million Pesticide concentrations are often small numbers. A detected level of 0.05 ppm equals 0.05 milligrams per kilogram. Regulatory action levels vary by jurisdiction and compound. If you are a patient with compromised immunity or organ transplants, even trace pesticide residues may be a concern. Ask your clinician what contaminants would be unsafe for your specific medical condition.
Residual solvents For concentrates, residual solvents like butane, propane, ethanol, or hexane are measured either in ppm or mg/kg. Good producers and labs should show “not detected” or levels well below health-based action limits. If solvents are listed without a detection limit or method, that is a warning sign.
Common red flags to watch for
sample identifiers missing or not matching the product; 2. no lab accreditation or vague method descriptions; 3. cannabinoid totals inconsistent with expected ranges for that product type; 4. any failed tests for microbial or heavy metal contamination; 5. terpene totals excessively low for cured flower, suggesting poor storage or adulteration.Context and trade-offs
Different labs use different validated methods and instruments. HPLC with diode-array detection or mass spectrometry is reliable for cannabinoids, while GC-MS is standard for volatile terpenes and solvents. Method sensitivity matters. A lab with low LOQs can detect and quantify small contaminant amounts that another lab might report as “not detected.” That does not necessarily mean one product is safer than another; it may mean you are comparing reports with different detection capabilities. When possible, choose labs with transparent methods and published LOQs.
Lab-to-lab variability is real. I have reviewed two CoAs for the same producer where the same batch tested at two labs showed a 10 percent relative difference in reported total THC. That degree of variance is common and often traces back to sample heterogeneity, differences in homogenization before testing, or analytical technique. For patients who require consistent dosing, request CoAs for each lot and, if possible, stick to the same producer and lot until you achieve a stable regimen.
Edge cases and special considerations
Edibles and dosing For edibles, a CoA must report total THC and CBD per serving and per package. If the report lists only the raw extract concentration without serving calculations, do the math: multiply mg/g by grams in the serving. Pay attention to homogeneity testing for multi-serving products. A manufacturer should demonstrate even distribution of cannabinoids; without homogeneity data, one piece might contain twice the intended dose.
Topicals and transdermal products Topicals often contain cannabinoids that do not fully penetrate the skin. CoAs for topicals should still report potency and contaminants, but efficacy cannot be inferred from potency alone. If you are using a topical for localized pain, expect the CoA to confirm cannabinoid levels and the absence of microbial contamination, but interpret therapeutic expectations conservatively.
High-CBD medical regimens If you rely on CBD for seizure control or severe spasticity, purity matters. Small amounts of delta-9 THC can have clinical consequences. A CoA that shows 0.3 percent THC may be acceptable for many patients but could be problematic where zero or near-zero THC is required by clinical guidance. For critical cases, seek full-spectrum reports with LOQs for THC below required thresholds, or choose broad-spectrum or CBD isolate products with corresponding CoAs.
Practical steps for patients and clinicians
Start by verifying the basics: batch match, sample date within a reasonable window, and lab accreditation. If you are a clinician recommending a product, ask the patient to bring the CoA or provide a link to a hosted PDF. Compare units and calculate per-dose amounts when dose titration is required. If a CoA shows any contaminant detection, check whether levels exceed action limits in your jurisdiction; if you cannot locate local limits, treat detected pesticides, heavy metals, or pathogenic microbes as grounds for discarding that batch for medical use.
An anecdote from practice I once advised a patient with severe COPD to stop using a vaporizer product that smelled unusually solvent-like. The CoA for that producer showed residual butane just under the regulatory limit, and another independent lab detected higher levels. The manufacturer adjusted their extraction protocol, and subsequent CoAs showed solvent levels below detection. The patient switched devices in the meantime and avoided a likely lung irritation episode. That case underlined two lessons: follow your nose and verify the CoA method and batch.
When to ask questions or request retesting
If a CoA lists an unexpected contaminant, contact the producer and the testing lab. Request a chain of custody and ask whether the lab ran confirmatory testing. For potency discrepancies greater than about 10 to 20 percent relative difference between label and CoA, ask the producer for clarification on whether label values represent total potency, single-analyte potency, or an average across multiple lots. Good producers welcome these questions and will provide batch-level traceability.
A short glossary of terms you will see
limit of detection (LOD), limit of quantitation (LOQ), measurement uncertainty; 2. total THC, THCA, CBD, CBDA, CBG, CBC; 3. HPLC, GC-MS, ICP-MS; 4. ppm (parts per million), mg/g, percent weight; 5. homogeneity, stability, chain of custody.Choosing a trusted CoA source
Prefer labs with ISO 17025 accreditation, transparent methods, and accessible LOQs. Producers who publish CoAs for every lot on their website demonstrate higher transparency than those who supply CoAs only on request. Look for third-party confirmatory testing when concerns arise. If a CoA seems overly abbreviated, lacks method names, or hides key identifiers, treat it as incomplete.
Final practical tips
Always compare like units when performing your own calculations. If a label says 10 mg THC per serving but the CoA lists percent weight, convert so you know the per-serving amount. Record CoA numbers for the product lot you use, and track effects relative to measured potency. When you see a new batch, check its CoA before relying on it clinically. For patients with special safety needs, such as transplant recipients or people on immunosuppressants, insist on CoAs that include a full pesticide and microbial panel.
Reading a CoA is a skill that pays off. It clarifies potency, informs dosing, and protects against contaminants. With a few minutes and attention to the metadata, cannabinoid math, contaminant panels, and lab methods, you turn a printed PDF into actionable, medical-grade information.